USC News

Menu Thursday, March 21, 2019 56° Partly Cloudy


Affordable drug policy
Sovaldi, shown here packaged for sale in France, is a hepatitis C treatment that is has gotten good results but costs up to $84,000 for a 12-week treatment in the United States. (Photo/Shutterstock)

A new way to pay for innovative drugs, provide universal access — and not break the bank

USC’s Neeraj Sood backs a novel approach in which a state contracts with a single manufacturer for a specific drug at a fixed rate, then can obtain as many pills as it needs. Louisiana is putting it to the test.